清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Community-Acquired Pneumonia: A Review

医学 社区获得性肺炎 肺炎 重症监护医学 内科学
作者
Valerie M. Vaughn,Robert P. Dickson,Jennifer K. Horowitz,Scott A. Flanders
出处
期刊:JAMA [American Medical Association]
卷期号:332 (15): 1282-1282 被引量:258
标识
DOI:10.1001/jama.2024.14796
摘要

Importance: Community-acquired pneumonia (CAP) results in approximately 1.4 million emergency department visits, 740 000 hospitalizations, and 41 000 deaths in the US annually. Observations: Community-acquired pneumonia can be diagnosed in a patient with 2 or more signs (eg, temperature >38 °C or ≤36 °C; leukocyte count <4000/μL or >10 000/μL) or symptoms (eg, new or increased cough or dyspnea) of pneumonia in conjunction with consistent radiographic findings (eg, air space density) without an alternative explanation. Up to 10% of patients with CAP are hospitalized; of those, up to 1 in 5 require intensive care. Older adults (≥65 years) and those with underlying lung disease, smoking, or immune suppression are at highest risk for CAP and complications of CAP, including sepsis, acute respiratory distress syndrome, and death. Only 38% of patients hospitalized with CAP have a pathogen identified. Of those patients, up to 40% have viruses identified as the likely cause of CAP, with Streptococcus pneumoniae identified in approximately 15% of patients with an identified etiology of the pneumonia. All patients with CAP should be tested for COVID-19 and influenza when these viruses are common in the community because their diagnosis may affect treatment (eg, antiviral therapy) and infection prevention strategies. If test results for influenza and COVID-19 are negative or when the pathogens are not likely etiologies, patients can be treated empirically to cover the most likely bacterial pathogens. When selecting empirical antibacterial therapy, clinicians should consider disease severity and evaluate the likelihood of a bacterial infection-or resistant infection-and risk of harm from overuse of antibacterial drugs. Hospitalized patients without risk factors for resistant bacteria can be treated with β-lactam/macrolide combination therapy, such as ceftriaxone combined with azithromycin, for a minimum of 3 days. Systemic corticosteroid administration within 24 hours of development of severe CAP may reduce 28-day mortality. Conclusions: Community-acquired pneumonia is common and may result in sepsis, acute respiratory distress syndrome, or death. First-line therapy varies by disease severity and etiology. Hospitalized patients with suspected bacterial CAP and without risk factors for resistant bacteria can be treated with β-lactam/macrolide combination therapy, such as ceftriaxone combined with azithromycin, for a minimum of 3 days.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白菜萝卜完成签到 ,获得积分10
7秒前
JJYYY完成签到,获得积分10
7秒前
尊敬的千凡完成签到,获得积分10
12秒前
KINGAZX完成签到 ,获得积分10
15秒前
huanhuan完成签到 ,获得积分10
21秒前
黑猫老师完成签到 ,获得积分10
25秒前
27秒前
lyb1853完成签到 ,获得积分10
36秒前
失眠的热狗完成签到,获得积分10
43秒前
57秒前
KalEl发布了新的文献求助10
57秒前
Nene完成签到 ,获得积分10
1分钟前
永乐完成签到 ,获得积分10
1分钟前
Gone完成签到,获得积分10
1分钟前
激动的似狮完成签到,获得积分0
1分钟前
1分钟前
1分钟前
机灵善斓完成签到,获得积分10
1分钟前
吃葡萄不吐葡萄皮的应助被HNO3采纳,获得10
1分钟前
1分钟前
syvshc完成签到,获得积分0
1分钟前
感动初蓝完成签到 ,获得积分10
1分钟前
害羞不凡完成签到,获得积分10
1分钟前
1分钟前
1分钟前
KalEl发布了新的文献求助10
1分钟前
molihuakai的应助被TingtingGZ采纳,获得10
2分钟前
呆萌尔风完成签到,获得积分10
2分钟前
2分钟前
怡然涫完成签到,获得积分10
2分钟前
佳伦完成签到 ,获得积分10
2分钟前
智者雨人完成签到 ,获得积分10
2分钟前
TingtingGZ发布了新的文献求助10
2分钟前
dada完成签到,获得积分10
2分钟前
2分钟前
rockyshi完成签到 ,获得积分10
2分钟前
调皮雅柔完成签到,获得积分10
2分钟前
独特的飞烟完成签到,获得积分10
2分钟前
专注的夜天完成签到,获得积分10
2分钟前
DianaLee完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780511
捐赠科研通 7767373
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697